Drugs / EADM
last change Dec 2024 re-read 2 minutes ago

EADM

Developed for
hepatocellular carcinoma
Investigated by
Sun Yat-sen University

Trials 1 · a red edge is where a trial was stopped

20192020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
NCT03591705 Jul 2018 → Dec 2023 hepatocellular carcinoma Sun Yat-sen University Unknown No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as EADM “transcatheter arterial chemo-lipiodolization with EADM 30mg/m2” NCT03591705
Route Other “transcatheter arterial chemo-lipiodolization” NCT03591705